Immunological monitoring after organ transplantation: Potential role of soluble CD30 Blood level measurement

Transplant Immunology

Volumn 17, Issue 4, 2007, Pages 283-287

  Truong, Dinh Quang ^a,b   Darwish, Ahmed A ^a   Gras, Jérémie ^a   Wieërs, Grégoire ^a   Cornet, Anne ^a   Robert, Annie ^a   Mourad, Michel ^a   Malaise, Jacques ^a   de Ville de Goyet, Jean ^a   Reding, Raymond ^a   Latinne, Dominique ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b University Medical Center   (Viet Nam)

Author keywords

Immune response; Organ transplantation; Rejection; Soluble CD30

Indexed keywords

CD30 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; LIVER GRAFT; LIVER GRAFT REJECTION; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD30; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-10; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; PROGNOSIS; RISK;

EID: 34247632070     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.01.007     Document Type: Article

References (15)

1. Susal C., Pelzl S., Simon T., and Opelz G. Advances in pre- and posttransplant immunologic testing in kidney transplantation. Transplant Proc 36 (2004) 29-34
2. Cinti P., Pretagostini R., Arpino A., Tamburro M.L., Mengasini S., Lattanzi R., et al. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations. Transplantation 79 (2005) 1154-1156
3. Durkop H., Latza U., Hummel M., Eitelbach F., Seed B., and Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68 (1992) 421-427
4. Martinez O.M., Villanueva J., Abtahi S., Beatty P.R., Esquivel C.O., and Krams S.M. CD30 expression identifies a functional alloreactive human T-lymphocyte subset. Transplantation 65 (1998) 1240-1247
5. Manetti R., Annunziato F., Biagiotti R., Giudizi M.G., Piccinni M.P., Giannarini L., et al. CD30 expression by CD8+ T cells producing type 2 helper cytokines: evidence for large numbers of CD8+CD30+ T cells clones in human immunodeficiency virus infection. J Exp Med 180 (1994) 2007-2011
6. Pellegrini P., Berghella A.M., Contasta I., and Adorno D. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Transpl Immunol 12 (2003) 49-61
7. Romagnani S., Del Prete G., Maggi E., Chilosi M., Caligaris-Cappio F., and Pizzolo G. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 57 (1995) 726-730
8. Pelzl S., Opelz G., Daniel V., Wiesel M., and Susal C. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 75 (2003) 421-423
9. Rajakariar R., Jivanji N., Varagunam M., Rafiq M., Gupta A., Sheaff M., et al. High pre-transplant soluble CD30 levels are predictive of the grade of rejection. Am J Transplant 5 (2005) 1922-1925
10. Susal C., Pelzl S., Dohler B., and Opelz G. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 13 (2002) 1650-1656
11. Slavcev A., Lacha J., Honsova E., Sajdlova H., Lodererova A., Vitko S., et al. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Transpl Immunol 14 (2005) 117-121
12. Warle M.C., Farhan A., Metselaar H.J., Hop W.C., van der Plas A.J., Kap M., et al. In vitro cytokine production of TNFalpha and IL-13 correlates with acute liver transplant rejection. Hum Immunol 62 (2001) 1258-1265
13. Reding R., Gras J., Truong D.Q., Wieers G., and Latinne D. The immunological monitoring of alloreactive responses in liver transplant recipients: a review. Liver Transpl 12 (2006) 373-383
14. Gerli R., Pitzalis C., Bistoni O., Falini B., Costantini V., Russano A., et al. CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. J Immunol 164 (2000) 4399-4407
15. Gerli R., Bistoni O., Lunardi C., Giacomelli R., Tomassini C., Biagini P., et al. Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy. Rheumatology 38 (1999) 1282-1284